Lv5
1230 积分 2024-01-30 加入
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
9天前
已完结
CADD-engineered peptide protacs efficiently target PCSK9 for hypercholesterolemia in vivo
19天前
已完结
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616
1个月前
已完结
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
1个月前
已完结
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
1个月前
已完结
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial
1个月前
已完结
Apelin receptors: From signaling to antidiabetic strategy
1个月前
已完结
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已完结
皖公网安备34019202002308
